236 related articles for article (PubMed ID: 26928949)
21. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
22. Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway.
Zhang C; Luo X; Chen J; Zhou B; Yang M; Liu R; Liu D; Gu HF; Zhu Z; Zheng H; Li L; Yang G
Diabetes; 2019 Oct; 68(10):1902-1914. PubMed ID: 31292134
[TBL] [Abstract][Full Text] [Related]
23. Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.
Garbacz WG; Lu P; Miller TM; Poloyac SM; Eyre NS; Mayrhofer G; Xu M; Ren S; Xie W
Mol Cell Biol; 2016 Nov; 36(21):2715-2727. PubMed ID: 27528620
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice.
Chen M; Bai M; Yi Y; Lu S; Luo J; Li P; Zhang H; Jiang H; Zhou H
Toxicol Lett; 2022 Jun; 363():1-10. PubMed ID: 35589016
[TBL] [Abstract][Full Text] [Related]
25. Cathelicidin suppresses lipid accumulation and hepatic steatosis by inhibition of the CD36 receptor.
Hoang-Yen Tran D; Hoang-Ngoc Tran D; Mattai SA; Sallam T; Ortiz C; Lee EC; Robbins L; Ho S; Lee JE; Fisseha E; Shieh C; Sideri A; Shih DQ; Fleshner P; McGovern DP; Vu M; Hing TC; Bakirtzi K; Cheng M; Su B; Law I; Karagiannides I; Targan SR; Gallo RL; Li Z; Koon HW
Int J Obes (Lond); 2016 Sep; 40(9):1424-34. PubMed ID: 27163748
[TBL] [Abstract][Full Text] [Related]
26. Sesamin ameliorates nonalcoholic hepatic steatosis by inhibiting CD36-mediated hepatocyte lipid accumulation in vitro and in vivo.
Bai YP; Zhang T; Hu ZY; Zhang Y; Wang DG; Zhou MY; Zhang Y; Zhang F; Kong X
Biochem Pharmacol; 2024 Jun; 224():116240. PubMed ID: 38679210
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
[TBL] [Abstract][Full Text] [Related]
28. Systemic Deficiency of GHR in Pigs leads to Hepatic Steatosis via Negative Regulation of AHR Signaling.
Han Q; Chen H; Wang L; An Y; Hu X; Zhao Y; Zhang H; Zhang R
Int J Biol Sci; 2021; 17(15):4108-4121. PubMed ID: 34803486
[TBL] [Abstract][Full Text] [Related]
29. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
30. Activation of aryl hydrocarbon receptor dissociates fatty liver from insulin resistance by inducing fibroblast growth factor 21.
Lu P; Yan J; Liu K; Garbacz WG; Wang P; Xu M; Ma X; Xie W
Hepatology; 2015 Jun; 61(6):1908-19. PubMed ID: 25614121
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.
Wolf Greenstein A; Majumdar N; Yang P; Subbaiah PV; Kineman RD; Cordoba-Chacon J
J Endocrinol; 2017 Jan; 232(1):107-121. PubMed ID: 27799461
[TBL] [Abstract][Full Text] [Related]
32. SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1α-LIPIN 1 pathway and increasing CD36 through Nrf2.
Barroso E; Rodríguez-Rodríguez R; Zarei M; Pizarro-Degado J; Planavila A; Palomer X; Villarroya F; Vázquez-Carrera M
Cell Commun Signal; 2020 Sep; 18(1):147. PubMed ID: 32912335
[TBL] [Abstract][Full Text] [Related]
33. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
34. Aryl hydrocarbon receptor deficiency protects mice from diet-induced adiposity and metabolic disorders through increased energy expenditure.
Xu CX; Wang C; Zhang ZM; Jaeger CD; Krager SL; Bottum KM; Liu J; Liao DF; Tischkau SA
Int J Obes (Lond); 2015 Aug; 39(8):1300-1309. PubMed ID: 25907315
[TBL] [Abstract][Full Text] [Related]
35. Hyperinsulinemia Enhances Hepatic Expression of the Fatty Acid Transporter Cd36 and Provokes Hepatosteatosis and Hepatic Insulin Resistance.
Steneberg P; Sykaras AG; Backlund F; Straseviciene J; Söderström I; Edlund H
J Biol Chem; 2015 Jul; 290(31):19034-43. PubMed ID: 26085100
[TBL] [Abstract][Full Text] [Related]
36. Homocysteine activates cAMP-response element binding protein in HepG2 through cAMP/PKA signaling pathway.
Woo CW; Siow YL; O K
Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1043-50. PubMed ID: 16497994
[TBL] [Abstract][Full Text] [Related]
37. Cluster of Differentiation 36 Deficiency Aggravates Macrophage Infiltration and Hepatic Inflammation by Upregulating Monocyte Chemotactic Protein-1 Expression of Hepatocytes Through Histone Deacetylase 2-Dependent Pathway.
Zhong S; Zhao L; Wang Y; Zhang C; Liu J; Wang P; Zhou W; Yang P; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Antioxid Redox Signal; 2017 Aug; 27(4):201-214. PubMed ID: 27967209
[TBL] [Abstract][Full Text] [Related]
38. Rapamycin-mediated CD36 translational suppression contributes to alleviation of hepatic steatosis.
Wang C; Yan Y; Hu L; Zhao L; Yang P; Moorhead JF; Varghese Z; Chen Y; Ruan XZ
Biochem Biophys Res Commun; 2014 Apr; 447(1):57-63. PubMed ID: 24685479
[TBL] [Abstract][Full Text] [Related]
39. Coordinate regulation of cytochrome P450 1a1 expression in mouse liver by the aryl hydrocarbon receptor and the beta-catenin pathway.
Braeuning A; Köhle C; Buchmann A; Schwarz M
Toxicol Sci; 2011 Jul; 122(1):16-25. PubMed ID: 21498875
[TBL] [Abstract][Full Text] [Related]
40. Novel roles for AhR and ARNT in the regulation of alcohol dehydrogenases in human hepatic cells.
Attignon EA; Leblanc AF; Le-Grand B; Duval C; Aggerbeck M; Rouach H; Blanc EB
Arch Toxicol; 2017 Jan; 91(1):313-324. PubMed ID: 27055685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
